Brooks Moore & Associates Inc. purchased a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 15,128 shares of the company's stock, valued at approximately $2,219,000.
Other hedge funds also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. increased its stake in Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after acquiring an additional 150 shares during the period. Park Square Financial Group LLC raised its position in Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock worth $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. lifted its stake in Procter & Gamble by 1,315.4% during the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company's stock worth $26,000 after purchasing an additional 171 shares during the period. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in Procter & Gamble during the second quarter valued at approximately $26,000. Finally, Litman Gregory Wealth Management LLC acquired a new stake in Procter & Gamble during the fourth quarter valued at approximately $26,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Down 0.0%
Shares of PG opened at $143.71 on Monday. The company has a market capitalization of $334.04 billion, a P/E ratio of 21.71, a PEG ratio of 4.43 and a beta of 0.39. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25. The business's 50 day simple moving average is $147.11 and its 200-day simple moving average is $148.21. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm had revenue of $21.20 billion during the quarter, compared to analysts' expectations of $21.38 billion. During the same period last year, the firm posted $1.48 EPS. The business's revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were paid a $1.0885 dividend. The ex-dividend date was Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble's dividend payout ratio (DPR) is 65.71%.
Insider Activity
In related news, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares of the company's stock, valued at $184,600.04. The trade was a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Marc S. Pritchard sold 4,030 shares of the company's stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. This trade represents a 2.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 6,627 shares of company stock worth $953,417. 0.20% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
PG has been the subject of a number of recent research reports. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a report on Wednesday, June 24th. Jefferies Financial Group upped their price target on Procter & Gamble from $177.00 to $179.00 and gave the company a "buy" rating in a research report on Friday, June 26th. Barclays increased their price objective on Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating for the company in a report on Thursday, July 16th. Finally, BMO Capital Markets boosted their target price on shares of Procter & Gamble from $169.00 to $170.00 and gave the company an "outperform" rating in a research note on Monday, June 29th. Thirteen analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $161.19.
Get Our Latest Report on PG
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.